EW
AGN

Evoke Wealth’s Allergan plc AGN Stock Holding History

Evoke Wealth’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-170
Closed -$30.2K – 1250
2020
Q1 		$30.2K Sell
170
-854
-83% -$161K ﹤0.01% 384
2019
Q4 		$196K Buy
1,024
+92
+10% +$16.6K 0.02% 224
2019
Q3 		$157K Buy
+932
New +$152K 0.02% 301

Other funds holding AGN

AJ
Ashburton (Jersey) St Helier, Jersey $227M AUM
C
Cerebellum San Francisco, California $21.5M AUM
B
Barings Charlotte, North Carolina $6.19B AUM 16.5% 1-Year Est. Return
JJ
JDC-JSC New York $20.8M AUM 30.94% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
OPS
Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return

Evoke Wealth's AGN Position: Q2 2020 in Review

Evoke Wealth sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 170 shares — an estimated $30.2K sold.

Evoke Wealth first reported a position in AGN in Q3 2019 and held it in 3 quarters. The position peaked at $196K in Q4 2019. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Evoke Wealth reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Evoke Wealth sold 170 Allergan plc shares in Q2 2020, an estimated $30.2K.
  • Evoke Wealth first reported a position in Allergan plc in Q3 2019 and held it in 3 quarters.
  • Evoke Wealth's Allergan plc position peaked at $196K in Q4 2019.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Evoke Wealth's 13F filing for Q2 2020, filed 10 Aug 2020.